Acute Kidney Injury Following Percutaneous Coronary Intervention
- PMID: 37690938
- DOI: 10.1016/j.amjcard.2023.08.057
Acute Kidney Injury Following Percutaneous Coronary Intervention
Keywords: acute kidney injury; contrast-induced nephropathy; percutaneous coronary intervention.
Conflict of interest statement
Declaration of Competing Interest Dr. Brilakis: consulting/speaker honoraria from Abbott Vascular, American Heart Association (associate editor Circulation), Amgen, Asahi Intecc, Biotronik, Boston Scientific, Cardiovascular Innovations Foundation (Board of Directors), CSI, Elsevier, GE Healthcare, IMDS, Medicure, Medtronic, Siemens, and Teleflex; research support: Boston Scientific, GE Healthcare; owner, Hippocrates LLC; shareholder: MHI Ventures, Cleerly Health, Stallion Medical. The remaining authors have no competing interests to declare.
Comment on
-
Post-contrast Acute Kidney Injury After Emergent and Elective Percutaneous Coronary Intervention (from the CREDO-Kyoto PCI/CABG Registry Cohort 3).Am J Cardiol. 2023 Sep 1;202:58-66. doi: 10.1016/j.amjcard.2023.06.031. Epub 2023 Jul 6. Am J Cardiol. 2023. PMID: 37421731
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources